Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

MS Veterans' fatigue and brain fog targeted in new study

NCT ID NCT07181811

First seen Oct 01, 2025 · Last updated May 22, 2026 · Updated 33 times

Summary

This study looks at whether ongoing ocrelizumab treatment helps with extreme tiredness and thinking skills (like memory and attention) in veterans with multiple sclerosis. About 30 veterans who have been on the drug for at least a year will be followed for 12 months. They will take memory tests and answer questions about fatigue and daily life at the start, 6 months, and 12 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • John D. Dingell VA Medical Center

    Detroit, Michigan, 48201, United States

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.